The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Think the frustration is with the share price ! Some £2 below broker fair value and floundering even with the spike today.
Unlikely to be a takeover candidate in view of security issues so have to just keep shouting the merits of this modest cap value company.
Nice one!
Bit thin on prospects for this year me thinks.
But still worth some re rating.
A grown up share price then!
A straight forward rights issue ( after sounding out institutional investors ) would do the trick after a very positive sales figure’s announcement if that is possible.
But where does Julian get his cash from to take up entitlement if he wants to maintain his % in the business?
Think we should wear flack jackets and wellington boots to guard against verbal muck flying around.
What a shame this local enterprise with so much promise a few years ago has ended up like this let alone the small local investors who are nursing huge losses whilst wanting to support local businesses.
Let’s hope BoD have some plan B if can keep the company alive.
Another company having to announce a revised date for results because accountants haven’t finished the job.
Such statements would in the past be interpreted as bad news for shareholders as suspicion of bad stuff being unearthed by accounting firm audit.
Now it seems it’s because they misjudge the time it takes to get audited and signed off.
Considering the fees paid to those outfits and the very limited choice of who you chose to get audited by I think we need the professional bodies to look at censoring firms that don’t deliver what they say and some financial journalists to research the number of times it’s happening.
On a quick read the figures and statements look very satisfactory. No drama, no over stating the quality of the results and considered opinions on future progress.
Wish there were more like Z!
Expect it will not enthuse the market in the current investor climate but this seems a well managed outfit with quality products selling to top brands and managing costs as well as any in the present mad world we live in.
And the brokers halved the target price from previous rec. Seems the co is doing everything right and still not being believed. With the history of these types of companies not good from the point of shareholder value I understand the scepticism but do hope I might have got one right!!
Agree with your sentiments. Just hope the background to him leaving is not a result of malpractice or finding skeletons in cupboards.
What will he do with his shareholding?’AGM end of month should be lively!
Looks positive and new sales have compensated the supply chain problems. Compared to Versarien this one seems to be going somewhere!
Figures look quite respectable in the circumstances, outlook encouraging and div up. And wad of cash in the bank. What’s not to like?!